This offering from IPG Health will emphasize equality among several different aspects of diversity, including race, gender, age and other intersectional groups throughout the clinical trial process.
4 campaigns that show there’s no secret recipe to diversity
The ALA is embarking on this clinical trial diversity push with the backing of several notable pharma companies: Daiichi Sankyo, Genentech, Novartis, Novocure and Merck.
MM+M Podcast 5.17.23: ‘No quick solution’: Genentech’s Highsmith talks progress, challenges on road to DE&I
Jack O’Brien interviews Quita Highsmith, Genentech’s chief diversity officer, about findings from the biotech’s third annual D&I report. Lecia Bushak explains why the DEA is extending pandemic-era telehealth flexibility for accessing controlled substances.
A California physician training program adds diversity, but where do graduates end up?
Enrollment is up, but there is not enough long-term tracking to know whether these medical school graduates return to practice in regions where they’re most needed.
Tension builds in transgender policy debate in Montana